Translate the text from Welsh to English.



 
Fis Mehefin diwethaf, lansiais y rhaglen Adferiad \- pecyn o wasanaethau gwerth £5m ar gyfer pobl sy’n gwella o effeithiau hirdymor COVID\-19 yng Nghymru, gan gynnwys COVID hir. Yn rhan o’r cyhoeddiad hwnnw, dywedais y buasem yn adolygu cynnydd y rhaglen bob chwe mis.


Yn fy Natganiad Llafar ar 8 Chwefror, rhoddais ddiweddariad i Aelodau’r Senedd ar ganlyniadau’r adolygiad cyntaf a’r gwaith a wnaethpwyd o ran datblygu gwasanaethau COVID hir. Cadarnheais hefyd y buaswn yn ystyried y blaenoriaethau ar gyfer y chwe mis nesaf er mwyn sicrhau bod y GIG yn gallu parhau i ddatblygu arbenigedd y gweithlu, addasu gwasanaethau i ddiwallu anghenion ein poblogaeth, a sicrhau bod y gwasanaethau hynny wedi’u hymgorffori yn rhan o’n cynlluniau ehangach o ran adfer wedi COVID\-19\.


Wrth inni barhau i ddelio â phwysau yr ymateb i’r pandemig, mae’n hanfodol bod y gwaith o ddatblygu gwasanaethau cymunedol yn cael ei gynnal er mwyn cefnogi’r rhai hynny sy’n gwella o effeithiau COVID\-19\. Rwyf felly yn cyhoeddi heddiw bod £5miliwn ychwanegol o gyllid y rhaglen Adferiad am gael ei ddyrannu i Fyrddau Iechyd yn ystod 2022/23 er mwyn cefnogi parhad eu gwasanaethau COVID hir.


Mae’r rhaglen Adferiad wedi ehangu a gwella gwasanaethau sylfaenol a gwasanaethau yn y gymuned ym mhob bwrdd iechyd. Rydym hefyd wedi datblygu llwybrau clir i wella’r cyfleoedd i bobl gael gafael ar ofal sy’n fwy arbenigol a chyflymu’r broses o gyfeirio at y gofal hynny. Ymddengys bod y model o wasanaethau adfer sy’n cael eu harwain gan y gymuned yn diwallu anghenion y rhai hynny sydd wedi defnyddio’r gwasanaethau ac anghenion clinigwyr fel modd effeithiol o gefnogi pobl.


Y gobaith erbyn diwedd y cyfnod chwe mis nesaf ym mis Gorffennaf yw y bydd byrddau iechyd yng Nghymru yn manteisio ar y cyfle i ddechrau ehangu’r model cymunedol i drin a chefnogi pobl sydd â chyflyrau hirdymor eraill sydd ag effeithiau tebyg i COVID hir, gan gynnwys cyflyrau megis Sglerosis Ymledol (MS), Enseffalomyelitis Myalgig (ME) a Syndrom Blinder Cronig. Byddai hyn o gymorth i sefydlu gwasanaethau ymyriadau hirdymor effeithiol, yn ogystal â sicrhau cysondeb wrth drin pobl sydd â gwahanol gyflyrau a diagnosisau.


Bydd y cyllid hefyd yn fodd o gefnogi parhad yr ap adfer hunanreoli COVID\-19 a’r *Canllawiau Cymru Gyfan ar reoli COVID hir*, sydd wedi bod yn adnoddau digidol effeithiol i gefnogi pobl i hunanreoli eu symptomau. Maent hefyd wedi bod o gymorth i roi’r cyngor a’r dysgu diweddaraf i weithwyr gofal iechyd proffesiynol er mwyn cefnogi’r broses o roi diagnosis o COVID hir a’i drin.


Rydym yn parhau i ddysgu rhagor am effeithiau hirdymor COVID\-19 a sut y mae’n gallu effeithio ar bobl mewn gwahanol ffyrdd. Rydym yn parhau i werthuso ein dull o drin pobl, eu cefnogi a gofalu amdanynt drwy ein model gwasanaeth unigryw fel y ffordd fwyaf effeithiol ac effeithlon o sicrhau’r canlyniadau gorau i bobl sy’n byw â COVID hir. Rydym hefyd yn parhau i gymryd rhan mewn nifer o astudiaethau ymchwil er mwyn deall y ffordd orau i gefnogi adferiad pobl.







Translation:


 
Last June, I launched the Adferiad programme – a £5m package of services for people who are recovering from the long\-term effects of COVID\-19 in Wales, including long COVID.  As part of that announcement, I said we would review the progress of the programme every six months.


In my Oral Statement on 8th February I provided Members of the Senedd with an update on the outcome of the first review and the progress made to develop long COVID services.  I also confirmed that I would be considering the priorities for the next six months so the NHS can continue to develop the expertise of our workforce, adapt services to meet the needs of our population and ensure these services are embedded as part of our wider COVID\-19 recovery planning. 


As we continue to respond to the demands of the pandemic response it is vital that the development of community services is maintained to support those who are recovering from the effects of COVID\-19\. So today I am announcing a further £5million of Adferiad programme funding to be allocated to Health Boards in 2022/23 to support the continuation of health boards’ long COVID services.


The Adferiad programme has expanded and enhanced primary and community\-based services in every health board and we have developed a clear pathway to improve access and speed up referral where people need more specialist care.  The model of community led rehabilitation services appears to be meeting the needs of those who have used the services and by clinicians as an effective way to support people.


It is hoped by the end of the next six\-month period in July, health boards in Wales will take the opportunity to begin to expand the community model to treat and support people with other long\-term conditions which have a similar impact as long COVID, including the likes of Multiple Sclerosis (MS), Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS).  This would help create effective long term intervention services and reduce variation treating people with different conditions and diagnoses.


The funding will also support the continuation of the self\-management COVID recovery app and *the All\-Wales guideline for the management of long COVID*, which have been effective digital tools in supporting people to self\-manage their symptoms and providing healthcare professionals with up\-to\-date advice and learning to support the diagnosis and treatment of long COVID.


We are continuing to learn more about the long\-term effects of COVID\-19 and how it can affect people in many different ways.  We continue to evaluate our approach of treating, supporting and managing people through our unique service model as the most efficient and effective way of achieving the best outcomes for people experiencing long COVID. We are also continuing to participate in several research studies to understand the best way to support people’s recovery.